# EDGAR Filing Document

**Accession Number:** 0001268854
**File Stem:** 0001127602-23-009138
**Filing Date:** 2023-3
**Character Count:** 11213
**Document Hash:** 6e3ffd594a1333e06df7a01ddd178bff
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-009138.hdr.sgml**: 20230306

**ACCESSION NUMBER**: 0001127602-23-009138

**CONFORMED SUBMISSION TYPE**: 3/A

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230306

**FILED AS OF DATE**: 20230306

**DATE AS OF CHANGE**: 20230306

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** SAUNDERS BRENT L
- **CENTRAL INDEX KEY:** 0001268854

**FILING VALUES:**
- **FORM TYPE:** 3/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41380
- **FILM NUMBER:** 23710203

**MAIL ADDRESS:**
- **STREET 1:** 2000 GALLOPING HILL ROAD
- **STREET 2:** C/O SCHERING PLOUGH CORP
- **CITY:** KENILWORTH
- **STATE:** NJ
- **ZIP:** 07033
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bausch & Lomb Corp
- **CENTRAL INDEX KEY:** 0001860742
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPHTHALMIC GOODS [3851]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 520 APPLEWOOD CRESCENT
- **CITY:** VAUGHAN
- **STATE:** A6
- **ZIP:** L4K 4B4
- **BUSINESS PHONE:** 908-541-5456

**MAIL ADDRESS:**
- **STREET 1:** 520 APPLEWOOD CRESCENT
- **CITY:** VAUGHAN
- **STATE:** A6
- **ZIP:** L4K 4B4

## Ex-24

```

POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes
and appoints each of Christina M. Ackermann, Alex Matheson and Debra E.
Levin, or any of them signing singly, and with full power of substitution,
the undersigned's true and lawful attorney-in-fact to:

(1)	prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments thereto, and
any other documents necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings with the SEC of reports
required by Section 16(a) of the Securities Exchange Act of 1934 (the
"Exchange Act") or any rule or regulation of the SEC;

(2)	execute for and on behalf of the undersigned, in the
undersigned's capacity as a director and/or officer of Bausch +
Lomb Corporation (the "Company"), Forms 3, 4 and 5  in accordance with
Section?16(a) of the Exchange Act and the rules thereunder;

(3)	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4 and 5 complete and execute any amendment
or amendments thereto, and timely file such form with the SEC and any
stock exchange or similar authority; and

(4)	take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney in
fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted.  The undersigned
acknowledges that the foregoing attorneys in fact, in serving in such
capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect
to the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

       [REMAINDER OF PAGE INTENTIONALY LEFT BLANK]

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed on the date set forth below.

By:  /s/ Brent L. Saunders
      Name: Brent L. Saunders
      Date: March 6, 2023

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3/A

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>SAUNDERS BRENT L<br><sub>(Last) (First) (Middle)</sub><br>C/O BAUSCH + LOMB CORPORATION<br>520 APPLEWOOD CRESCENT<br><sub>(Street)</sub><br>VAUGHAN, A6 L4K 4B4<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CEO and Chair_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Bausch & Lomb Corp [ BLCO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Shares, No Par Value |  |  |  |  |  |  |  | 375000<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Non-Qualified Stock Options (right to purchase) | $18.60 |  |  |  |  |  |  | <sup>(2)</sup> | <sup>(3)</sup> | Common Shares, No Par Value | 1318681<sup>(2)</sup> |  |  | D |  |
| Performance Stock Units | $0 |  |  |  |  |  |  | <sup>(4)(5)</sup> | <sup>(4)(5)</sup> | Common Shares, No Par Value | 750000<sup>(4)(5)</sup> |  |  | D |  |

---

### Footnotes:

(1) Reflects an award of restricted stock units ("RSUs") granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") on February 23, 2023. Each RSU reflects the right to receive one common share, no par value ("Common Share"), of Bausch + Lomb Corporation (the "Company"), subject to the terms of the Plan and the applicable award agreement. The RSUs are scheduled to vest 50% on the second anniversary of the grant date and the remaining 50% on the third anniversary of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date.

(2) Reflects an award of stock options to purchase Common Shares granted to the reporting person under the Plan on February 23, 2023. Each stock option reflects the right to purchase one Common Share, subject to the terms of the Plan and the applicable award agreement. The stock options are scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject generally to the reporting person's continued employment through the applicable vesting date.

(3) The stock options will expire on the tenth anniversary of the grant date.

(4) Represents an award of performance stock units ("PSUs") granted to the reporting person under the Plan on February 23, 2023. Each PSU reflects the right to receive one Common Share, subject to the terms of the Plan and the applicable award agreement. The target number of shares underlying the PSUs is 750,000 Common Shares, and the maximum number of shares underlying the PSUs is 2,250,000 Common Shares.

(5) The PSUs may be earned and vest between 0% and 300% based on achievement of specified share price performance goals (and, if applicable, a relative total shareholder return performance goal), calculated as of the fourth anniversary of the grant date (the "Measurement Date"), subject generally to the reporting person's continued employment through the Measurement Date.

**Remarks:**
No equity changes to originally filed Form 3; submitting Form 3/A to include Limited Power of Attorney.

**Signature:** /s/ Debra E. Levin, attorney-in-fact  
**Date:** 2023-03-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**